Total Payments
$1,035
2024 Payments
$122.35
Companies
19
Transactions
57
Medicare Patients
991
Medicare Billing
$76,342
Payment Breakdown by Category
Food & Beverage$1,035 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,035 | 57 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $218.38 | 11 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $146.41 | 9 | $0 (2022) |
| Celgene Corporation | $138.71 | 8 | $0 (2023) |
| Merck Sharp & Dohme LLC | $110.24 | 6 | $0 (2022) |
| Daiichi Sankyo Inc. | $75.40 | 4 | $0 (2023) |
| Amgen Inc. | $60.27 | 4 | $0 (2023) |
| PFIZER INC. | $59.29 | 3 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $27.05 | 1 | $0 (2023) |
| ARRAY BIOPHARMA INC | $24.36 | 1 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $22.33 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $122.35 | 6 | Novartis Pharmaceuticals Corporation ($43.16) |
| 2023 | $232.66 | 12 | Novartis Pharmaceuticals Corporation ($49.00) |
| 2022 | $271.27 | 15 | E.R. Squibb & Sons, L.L.C. ($83.57) |
| 2021 | $408.62 | 24 | Celgene Corporation ($84.37) |
All Payment Transactions
57 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/31/2024 | PFIZER INC. | BOSULIF (Drug), ELREXFIO, ADCETRIS | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 10/10/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $24.21 | General |
| Category: Oncology | ||||||
| 02/29/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Oncology | ||||||
| 02/15/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: Oncology | ||||||
| 01/19/2024 | PFIZER INC. | BOSULIF (Drug), BESPONSA, COMIRNATY | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 01/17/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: ONCOLOGY | ||||||
| 12/15/2023 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: ONCOLOGY | ||||||
| 11/29/2023 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: Iron Deficiency Anemia | ||||||
| 11/16/2023 | PFIZER INC. | INLYTA (Drug), XTANDI, TALZENNA | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: ONCOLOGY | ||||||
| 10/20/2023 | Amgen Inc. | Blincyto (Biological), Kyprolis | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: Oncology | ||||||
| 10/19/2023 | Novartis Pharmaceuticals Corporation | KISQALI (Drug), PIQRAY | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Oncology | ||||||
| 08/16/2023 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: Iron Deficiency Anemia | ||||||
| 05/11/2023 | Amgen Inc. | LUMAKRAS (Drug) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: Oncology | ||||||
| 03/09/2023 | Bayer HealthCare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Oncology | ||||||
| 02/16/2023 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $13.67 | General |
| Category: Hematology | ||||||
| 02/09/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | GILOTRIF (Drug) | Food and Beverage | In-kind items and services | $27.05 | General |
| Category: ONCOLOGY | ||||||
| 01/26/2023 | Novartis Pharmaceuticals Corporation | KISQALI (Drug), PIQRAY | Food and Beverage | In-kind items and services | $32.64 | General |
| Category: Oncology | ||||||
| 01/12/2023 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: HEMATOLOGY | ||||||
| 12/13/2022 | Boston Scientific Corporation | General - Vascular Intervention (Device) | Food and Beverage | In-kind items and services | $11.87 | General |
| Category: General - Vascular Intervention_PI | ||||||
| 11/16/2022 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $18.33 | General |
| Category: Oncology | ||||||
| 10/28/2022 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug) | Food and Beverage | In-kind items and services | $24.20 | General |
| Category: ONCOLOGY | ||||||
| 08/18/2022 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $20.72 | General |
| 08/11/2022 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $19.15 | General |
| Category: Hematology | ||||||
| 07/20/2022 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $14.85 | General |
| Category: Oncology | ||||||
| 07/07/2022 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 288 | 446 | $48,285 | $21,601 |
| 2022 | 6 | 269 | 395 | $45,760 | $21,849 |
| 2021 | 5 | 226 | 322 | $40,105 | $20,195 |
| 2020 | 5 | 208 | 257 | $30,165 | $12,696 |
Total Patients
991
Total Services
1,420
Medicare Billing
$76,342
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 109 | 180 | $27,000 | $13,144 | 48.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 77 | 103 | $10,300 | $4,921 | 47.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 32 | 36 | $3,600 | $1,713 | 47.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 19 | 19 | $2,850 | $966.63 | 33.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 12 | 13 | $780.00 | $408.38 | 52.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 22 | 51 | $3,315 | $402.15 | 12.1% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 17 | 44 | $440.00 | $45.76 | 10.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 95 | 162 | $24,300 | $12,595 | 51.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 83 | 115 | $11,500 | $5,633 | 49.0% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 44 | 49 | $4,900 | $2,397 | 48.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 21 | 21 | $3,150 | $969.68 | 30.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 15 | 26 | $1,690 | $226.26 | 13.4% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2022 | 11 | 22 | $220.00 | $29.09 | 13.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 117 | 179 | $26,850 | $13,926 | 51.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 62 | 84 | $8,400 | $4,708 | 56.0% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 23 | 23 | $3,450 | $1,385 | 40.1% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 13 | 19 | $1,235 | $153.56 | 12.4% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2021 | 11 | 17 | $170.00 | $23.29 | 13.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 68 | 91 | $13,650 | $5,952 | 43.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 81 | 107 | $10,700 | $4,484 | 41.9% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 22 | 22 | $3,300 | $1,241 | 37.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 19 | 19 | $1,840 | $845.50 | 46.0% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2020 | 18 | 18 | $675.00 | $173.56 | 25.7% |
About Nancy Collins, FNP
Nancy Collins, FNP is a Family healthcare provider based in Douglas, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2015. The National Provider Identifier (NPI) number assigned to this provider is 1033586615.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Nancy Collins, FNP has received a total of $1,035 in payments from pharmaceutical and medical device companies, with $122.35 received in 2024. These payments were reported across 57 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($1,035).
As a Medicare-enrolled provider, Collins has provided services to 991 Medicare beneficiaries, totaling 1,420 services with total Medicare billing of $76,342. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Douglas, GA
- Active Since 08/30/2015
- Last Updated 03/07/2023
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1033586615
Products in Payments
- KISQALI (Drug) $125.45
- KEYTRUDA (Biological) $110.24
- OPDIVO (Biological) $94.91
- INJECTAFER (Drug) $75.40
- REBLOZYL (Biological) $68.38
- ONUREG (Drug) $48.81
- FEMARA (Drug) $42.15
- BOSULIF (Drug) $39.56
- PROMACTA (Drug) $38.78
- LIBTAYO (Biological) $31.86
- ELIQUIS (Drug) $30.78
- LUMAKRAS (Drug) $30.52
- GILOTRIF (Drug) $27.05
- BRAFTOVI (Drug) $24.36
- FRUZAQLA (Drug) $22.33
- Lenvima (Drug) $22.25
- Revlimid (Drug) $21.52
- INLYTA (Drug) $19.73
- MONOFERRIC (Drug) $19.47
- FERAHEME (Drug) $17.59
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Douglas
Farah Smith, Np-C, NP-C
Family — Payments: $12,128
Family $12,128
Mrs. Haley Lewis, Np-C, NP-C
Family — Payments: $7,894
Family $7,894
Teresa Wilson, Np-C, NP-C
Family — Payments: $7,533
Family $7,533
Katie Davis, Np-C, NP-C
Family — Payments: $7,207
Family $7,207
Mrs. Shanda Carter, Np, NP
Family — Payments: $4,317
Family $4,317
Candace Musgrove, Np, NP
Family — Payments: $4,300
Family $4,300